Genzyme and Isis Receive Corporate Award from the National Organization for Rare Disorders (NORD) for the Development of KYNAMRO®

[Business Wire] – Genzyme, a Sanofi company , and Isis Pharmaceuticals Inc. , today announced that they have received the 2014 Partners in Progress Corporate Award from NORD in recognition of KYNAMRO® injection. more

View todays social media effects on SNY

View the latest stocks trending across Twitter. Click to view dashboard

See who Sanofi is hiring next, click here to view